GL1X · GenesisL1 explorer

MolNFT v1 · #128566 · protein

Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (lg-laf-clp)

5NUN: “Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (lg-laf-clp)”. X-ray diffraction, 1 ligand (Z80), 1 pocket (best druggability 0.59). MolNFT v1 #128566 on GenesisL1: 3D structure, binding sites…

PDB
5NUN
Type
protein
Length
159 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactoglobulin
UniProt
P02754
Ligands
Z80
Pockets
1 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactoglobulinprotein15916% helix, 42% strandP02754

Ligands and binding sites

  • Z80 · 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12530.590.7823Z80

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 5NUN · Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.